Emerging Therapies for Pruritus in PBC
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this podcast, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, discuss emerging therapies currently in clinical trials for the management of PBC that can dramatically affect patients’ quality of life.
Decera Clinical Education Infectious Disease Podcast · Marlyn J. Mayo MD, Stuart C. Gordon MD, Pam Rivard RN
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.
Listen as they discuss:
- Gaps in current management
- Patient perspectives: why we should not dismiss itching as an underlying psychologic problem
- PPAR agonists and how they affect pruritus
- BEZURSO and FITCH
- ELATIVE
- ENHANCE and RESPONSE
- IBATs (inhibitors of bile acid transport)
- GLIMMER
- Common questions
Presenters:
Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas
Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan
Pam Rivard, RN
Person living with PBC
Link to full program:
https://bit.ly/3Dnfb2E
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.